![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
RxMD signs drug development agreement with GlycoRegImmune
RxMD has collaborated with GlycoRegImmune (GRI) to develop new treatments by using GRI's novel natural...
Evotec, Roche collaborate to develop oncology biomarkers
Evotec has entered into an oncology research and development agreement with Roche to organize multiple...
Evotec and PsychoGenics Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery...
Evotec AG announced that it has entered into a strategic alliance with PsychoGenics Inc. to...
Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Drug Delivery of BA058
Radius Health, Inc. and 3M Drug Delivery Systems announced an agreement to collaborate on the...
Phase 3 Data Demonstrate XGEVA(TM) (Denosumab) is First Bone Targeted Therapy to Prevent Spread...
Amgen announced primary results of a pivotal Phase 3 trial ('147) demonstrating that XGEVA(TM) (denosumab)...
Utilising a CTMS to Create a Development Edge
As clinical trials become more globalised and complex, there is an increased need for investigators...
InhibOx and COSMIC Discoveries align to deliver full service drug discovery offering
New service supports big pharma’s drive to outsourcing by offering highly sophisticated technologies for drug...
Scientist gets his mind around Alzheimer’s
It’s not known what causes the disease or how to cure it. And the stakes...
Lycera Announces Research Collaboration with Merck
Lycera Corporation, a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat...
Shire Strengthens Specialty Pharmaceuticals Team with Senior R&D Appointments
Shire plc, the global specialty biopharmaceutical company, today announced the appointment of two senior Research...